New JHG002 therapy aims to ease chronic back pain in clinical trial

NCT ID NCT07304076

Recruiting now Symptom relief Sponsor: Jaseng Medical Foundation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a treatment called JHG002 for people with chronic low back pain lasting 6 months or more. About 96 adults aged 19 to 69 will receive the therapy, and researchers will measure how much their pain changes over 6 weeks. The goal is to see if JHG002 safely reduces pain, not to cure the condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LOW-BACK PAIN (CLBP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC LOW-BACK PAIN (CLBP)

Contacts and locations

Locations

Bucheon Jaseng Hospital of Korean Medicine
RECRUITING

Bucheon-si, GGyeonggi-do, 14598, South Korea
Dongguk University Bundang Oriental Hospital
RECRUITING

Seongnam, GGyeonggi-do, 13601, South Korea
Jaseng Hospital of Korean Medicine
RECRUITING

Seoul, Gangnam-Gu, 06110, South Korea
Kyung Hee University Korean Medicine Hospital at Gangdong
RECRUITING

Seoul, Gangdong-gu, 05278, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.